Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Marco Bergevin"'
Publikováno v:
European Journal of Medical Research, Vol 27, Iss 1, Pp 1-6 (2022)
Abstract Background The different clinical manifestations, from none to severe, and the variability in efficacy of SARS-CoV-2 diagnosis by upper respiratory tract testing, make diagnosis of COVID-19 and prevention of transmission especially challengi
Externí odkaz:
https://doaj.org/article/31a1fd1d61e448d198725e399976b2c0
Autor:
George G. Zhanel, Justin Kosar, Melanie Baxter, Rita Dhami, Sergio Borgia, Neal Irfan, Kelly S. MacDonald, Gordon Dow, Philippe Lagacé-Wiens, Maxime Dube, Marco Bergevin, Carlo Tascini, Yoav Keynan, Andrew Walkty, James Karlowsky
Publikováno v:
Journal of Global Antimicrobial Resistance, Vol 24, Iss , Pp 335-339 (2021)
Objectives: Ceftobiprole is an advanced-generation cephalosporin with a favourable safety profile. Published data on the clinical use of ceftobiprole are limited. We report use of ceftobiprole in Canadian patients using data captured by the CLEAR reg
Externí odkaz:
https://doaj.org/article/280243864b9146c38bb05f49667fa5e1
Publikováno v:
Virology Journal, Vol 17, Iss 1, Pp 1-10 (2020)
Abstract Background The fight against the COVID-19 pandemic has created an urgent need to rapidly detect infected people. The challenge for clinical laboratories has been finding a high throughput, cost-efficient, and accurate testing method in the c
Externí odkaz:
https://doaj.org/article/e41c5b7d551b4d9b87bb9d768d3e12eb
Publikováno v:
Emerging Infectious Diseases, Vol 23, Iss 5, Pp 865-867 (2017)
We describe a case of methicillin-resistant Staphylococcus aureus (MRSA) enterocolitis in a healthy adult with previous antibiotic exposure. Colonoscopy revealed diffuse colitis and mild ileitis without ulceration. Stool cultures demonstrated abundan
Externí odkaz:
https://doaj.org/article/37a5631ae0aa43fbbe4902c34f141058
Autor:
James A. Karlowsky, Marco Bergevin, Andrew Walkty, Sergio Borgia, Yoav Keynan, Neal Irfan, Rita Dhami, Melanie R. Baxter, George G. Zhanel, Maxime Dube, Justin Kosar, Carlo Tascini, Gordon Dow, Philippe Lagacé-Wiens, Kelly MacDonald
Publikováno v:
Journal of Global Antimicrobial Resistance, Vol 24, Iss, Pp 335-339 (2021)
Objectives Ceftobiprole is an advanced-generation cephalosporin with a favourable safety profile. Published data on the clinical use of ceftobiprole are limited. We report use of ceftobiprole in Canadian patients using data captured by the CLEAR regi
Publikováno v:
European journal of medical research. 27(1)
Background The different clinical manifestations, from none to severe, and the variability in efficacy of SARS-CoV-2 diagnosis by upper respiratory tract testing, make diagnosis of COVID-19 and prevention of transmission especially challenging. In ad
Autor:
Judith Fafard, Philippe J. Dufresne, Emilie Vallières, Julie Bestman-Smith, Annie-Claude Labbé, Jean Longtin, Marco Bergevin, Marc Desforges, Jeannot Dumaresq, François Coutlée
Publikováno v:
Journal of Clinical Virology
Background Nasopharyngeal swab has long been considered the specimen of choice for the diagnosis of respiratory viral infections, including SARS-CoV-2 infection, but it suffers from several drawbacks: its discomfort limits screening acceptability, an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aa231cf6074e77d9282f8f3a2b0f5394
https://doi.org/10.1101/2021.03.11.21251938
https://doi.org/10.1101/2021.03.11.21251938
Publikováno v:
Can Urol Assoc J
Introduction: Some authors advocate an increase in post-prostate needle biopsy (PNB) infections associated with emergent quinolone resistance in E. coli, urging re-evaluation of antibioprophylaxis. In this study, we compared rates of post-PNB uroseps
Publikováno v:
Journal of Urology. 201
Autor:
Marthe Kenny Charles, Marco Bergevin, George G. Zhanel, Andrew Walkty, Amrita Bharat, Heather J. Adam, Melanie R. Baxter, David A. Boyd, James A. Karlowsky, Michael R. Mulvey
Publikováno v:
Diagnostic microbiology and infectious disease. 94(2)
Pan-aminoglycoside (amikacin, gentamicin, tobramycin, plazomicin)–resistant Escherichia coli and Klebsiella pneumoniae clinical isolates from patients in Canadian Hospitals (2013–2017) were evaluated by whole genome sequencing for 16S ribosomal R